Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)
Status:
Completed
Trial end date:
2004-07-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the optimal dose of sugammadex when this compound
is administered during deep neuromuscular block. Sugammadex is administered shortly (5
minutes) after administration of a high dose (1.2 mg/kg) of the neuromuscular blocking agent
rocuronium . Under these circumstance the neuromuscular block is deep. The safety and
pharmacokinetics of sugammadex are also studied.